Jacques Mulder, the former global leader of EY’s Healthcare practice, has joined Alvarez & Marsal as a Managing Director.
Mulder brings more than 25 years of consulting and industry experience to the role. Most recently, he was a President at Ciox Health, a healthcare information management company based in Georgia. Before that, Mulder was the global and US leader of EY’s Healthcare practice, responsible for leading the firm’s advisory offerings including strategy, mergers & acquisitions, performance improvement, operational excellence and digital transformation.
Prior to joining EY, he worked a decade for rival Big Four accounting and consulting firm, where he established, developed and built Deloitte Consulting’s Life Sciences practice and latterly served as Chief Strategy Officer for the Life Sciences & Healthcare industry vertical, leading the development and execution of Deloitte’s domestic strategy for the sector.
During his tenure at the two Big Four giants, Mulder advised clients on transformation initiatives in sales and marketing, research and development, launches of new products and services and the development of strategic alliances and partnerships. He also advised clients on diligence efforts for strategic investment and product acquisitions. He also was advised on a large merger integration process.
Earlier in his career, he worked for among others Quintiles (now IQVIA), The Lewin Group (now a subsidiary of Optum), and for Abbott Laboratories and GlaxoSmithKline in Sub Saharan Africa.
At Alvarez & Marsal (A&M), one of the globe’s larger management consulting firms, Miami-based Mulder is part of the Healthcare industry group, and will focus on the pharmaceutical and medtech sectors. He will leverage his deep expertise and knowledge in the field to help the firm’s clients with strategic transformations, business improvement and innovation.
Martin McGahan, Head of Alvarez & Marsal’s Healthcare practice, said: “Jacques’ in-depth sector knowledge and experience significantly boost A&M’s capabilities to offer integrated solutions that maximize value and drive long-term results for the pharmaceutical and device industries. He will help our clients meet critical market demand,” he said, referring to the spike in demand for pharma products amid the current Covid-19 pandemic.
Jacques Mulder holds a bachelor’s degree in physiology and biomechanics from Clemson University and an MBA (with specialisation in finance and competitive strategy) from the Edinburgh Business School in Scotland.